More than 21% of US adults take lipid-lowering statin medications; however, the CDC states that many more people should be doing so. But who is eligible? The guidelines of the USPSTF, the American College of Cardiology/American Heart Association and the…
Exogenous oxytocin (Pitocin) may be the most commonly used drug in obstetrics but it is not benign. Its use in clinical practice is riddled with myths, unsubstantiated by science, that perpetuate poor practice habits. Misuse, overuse, and sometimes abuse in…
Medical error is the third leading cause of death in the US and technology failure is to blame 44% of the time. Perinatal clinicians are frequently unaware of the equipment limitations they use routinely. Non-invasive blood pressure machines, pulse oximeters,…
The obstetric malpractice claim of “a delay in treatment of fetal distress” remains the number one factor In over 20% of claims from multiple PIAA resources. The key to avoiding delaying treatment to a fetus in distress is to recognize…
© 2025
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
